Abstract
Nocturnal deterioration of lung function frequently occurs in asthma patients. It results in sleep depravation and impaired quality of life but is also associated with increased morbidity and mortality. Several mechanisms such as endogenous circadian rhythm disturbances, concomitant disorders, behavioral and environmental factors have been implicated in the pathophysiology of nocturnal asthma symptoms. Appropriately used, currently available asthma medications, including long acting beta agonists and inhaled corticosteroids are effective in therapy of nocturnal asthma symptoms in the majority of patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
National Asthma Education and Prevention Program, Expert panel report 2; guidelines for diagnosis and prevention of asthma. Publication No 97–405. Bethesda, MD: National Institute of Health; April 1997.
Hetzel MR, Clark TJH, Braithwaite MA. Analysis of sudden deaths and ventilatory arrests in hospital. Br Med J 1977; 1: 808–11.
Cochrane GM, Clark TJH. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. Thorax 1975; 30: 300–5.
Dathlefsen U, Repgas R. Ein neues Terapieprinzip bei Nachtlichen Asthma. Klin Med 1985; 80: 44–7.
Raherison C, Abouelfath A, Le Gros V, Taytard A, Molimard M. Underdiagnosing of nocturnal symptoms in asthma in general practice. J Asthma 2006; 43: 199–202.
Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85 (Suppl 1B): 6–8.
Tomalak W, Elbousefi A, Kurzawa R, et al. Diurnal variations of respiratory system resistance and compliance derived from input impedance in asthmatic children. Respir Physiol 2000; 123: 101–8.
Diette GB, Markson L, Skinner EA, et al. Nocturnal asthma in children affects school performance, and parents' work attendance. Arch Pediatr Adolesc Med 2000; 154: 923–8.
Weersink EJM, van Zomeren EH, Koeter GH, et al. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respr Crit Care Med 1997; 156: 1144–50.
Global Initiative for Asthma, 11/2006, WHO
Mortola JP. Breathing around the clock: an overview of the circadian pattern of respiration. Eur J Appl Physiol 2004; 91: 119–29.
Spengler CM, Shea SA. Endogenous circadian rhythm of pulmonary function in healthy humans. Am J Respir Crit Care Med 2000; 162: 1038–42.
Spengler CM, Czeisler CA, Shea SA. An endogenous circadian rhythm of respiratory control in humans. J Physiol 2000; 526: 683–94.
Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732–8.
Shigemitsu H, Afshar K. Nocturnal asthma. Curr Opinion Pulm Med 2007; 13: 49–55.
Sutherland ER. Nocturnal asthma. J Allergy Clin Immunol 2005; 116: 1179–86.
Calhoun WJ. Nocturnal asthma. Chest 2003; 123: S399–S405.
Skloot GS. Nocturnal astma: mechanisms and management. Mt Sinai J Med 2002; 69: 140–7.
Di Stefano A, Lusuardi M, Braghiroli A, Donner CF. Nocturnal asthma: mechanisms and therapy. Lung 1997; 175: 53–61.
DuBuske LM. Asthma: diagnosis and management of nocturnal symptoms. Compr Ther 1994; 20: 628.
Ballard RD, Saathoff MC, Patel DK, Kelly PL, Martin RJ. Effect of sleep on nocturnal bronchoconstriction and ventilatory patterns in asthmatics. J Appl Physiol 1989; 67: 243–9.
Kales A, Beall GN, Bajor GR, et al. Sleep studies in asthmatic adults: relationship of attacks to sleep stage and time of night. J Allergy 1968; 41: 164–73.
Hetzel MR, Clark TJH. Does sleep cause nocturnal asthma? Thorax 1979; 34: 749–54.
Clark TJH, Hetzel MR. Diurnal variation in asthma. Br J Dis Chest 1977; 71: 87–92.
Bonjer FH. Physiological aspects of shift work. Proc Int Congr Occup Health 1960; 13: 848–51.
Martin RJ, Cicutto LC, Ballard RD. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990; 141: 33–8.
Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway caliber. Thorax 1982; 37: 423–9.
Oosterhoff Y, Koeter GH, De Monchy JG, Postma DS. Circadian variation in airway responsiveness to metacholine, propranolol, and AMP in atopic asthmatic subjects. Am Rev Respir Dis 1993; 147: 512–7.
Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J 2002; 20: 841–5.
Covar RA, Szefler SJ, Martin RJ, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 2003; 142: 469–75.
ten Hacken NH, van der Vaart H, van der Mark TW, et al. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Respir Crit Care Med 1998; 158: 902–7.
Georges G, Bartelson BB, Martin RJ, Silkoff PE. Circadian variation in exhaled nitric oxide in nocturnal asthma. J Asthma 1999; 36: 467–73.
Silkoff PE, McClean PA, Slutsky AS, et al. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 1998; 35: 473–9.
Mohiouddin AA, Martin RJ. Circadian basis of the late asthmatic response. Am Rev Respir Dis 1990; 142: 1153–7.
Bates ME, Clayton M, Calhoun W, et al. Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma. Am J Respir Crit Care Med 1994; 149: 667–72.
Kelly EAB, Houtman JJ, Jarjour NN. Inflammatory changes associated with circadian variation in pulmonary function in subjects with mild asthma. Clin Exp Allergy 2004; 34: 227–33.
Calhoun WJ, Bates ME, Schrader L, Sedgwick JB, Busse WW. Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis 1992; 145: 577–81.
Gresele P, Dottorini M, Selli ML, et al. Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma. J Allergy Clin Immunol 1993; 91: 894–902.
Mackay TW, Wallace WAH, Howie SEM, et al. Role of inflammation in nocturnal asthma. Thorax 1994; 149: 667–72.
Martin RJ, Cicutto LC, Smith HR, Ballard RD, Szefler SJ. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143: 351–7.
Postma DS, Oosterhoff Y, van Aalderen WMC, et al. Inflammation in nocturnal asthma? 1994; 150: S83–6.
Oosterhoff Y, Hoogsteden HC, Rutgers B, Kauffman HF, Postma DS. Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma. Am J Respir Crit Care Med 1995; 151: 75–81.
Jarjour NN, Busse WW, Calhoun WJ. Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992; 146: 905–11.
Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. A J Respir Crit Care Med 1995; 152: 1474–7.
Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505–10.
Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999; 159: 228–34.
Kraft M, Pak J, Martin RJ, Kaminsky D, Irvin CG. Distal lung dysfunction at night in nocturnal asthma patients. Am J Respir Crit Care Med 2001; 163: 1551–6.
Meijer GG, Postma DS, van der Heide S, et al. Exogenous stimuli and circadian peak expiratory flow variation in allergic asthmatic children. Am J Respir Crit Care Med 1996; 153: 237–42.
Szefler SJ, Ando R, Cicutto LC, et al. Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49: 59–68.
Haen E, Hauck R, Emslander HP, et al. Nocturnal asthma. Beta 2-adrenoreceptors on peripheral mononuclear leukocytes, cAMP- and cortisol-plasma concentrations. Chest 1991; 100: 1239–45.
Sutherland ER, Ellison MC, Kraft M, Martin RJ. Altered pituitary-adrenal interaction in nocturnal asthma. J Allergy Clin Immunol 2003; 112: 52–7.
Kraft M, Vianna E, Martin RJ, Leung DYM. Nocturnal asthma is associated with reduced glucocorticoid receptor (GR) binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999; 103: 66–71.
Kraft M, Hamid Q, Chrousos GP, Martin RJ, Leung DYM. Decreased steroid responsiveness at night in nocturnal asthma. Am J Respir Crit Care Med 2001; 163: 1219–25.
Turki J, Pak J, Green SA, et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95: 1635–41.
Morrison JF, Pearson SB, Dean HG. The parasympathetic nervous system in nocturnal asthma. BMJ 1988; 296: 1427–9.
Barnes P, FitzGerald G, Brown M, Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine and cortisol. N Engl J Med 1980; 303: 263–7.
Sutherland RE, Ellison MC, Kraft M, Martin RJ. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003; 112: 513–7.
Sutherland ER, Martin RJ, Ellison MC, Kraft M. Immunomodulatory effect of melatonin in asthma. Am J Respir Crit Care Med 2002; 166: 1055–61.
Gislason T, Janson C, Vermeire P, et al. Respiratory symptoms and nocturnal gastroesophageal reflux: a population based survey of young adults in three European countries. Chest 2002; 121: 158–63.
Bohadana AB, Hannhart B, Teculescu DB. Nocturnal worsening of asthma and sleep-disorder breathing. J Asthma 2002; 39: 85–100.
Chan CS, Woolcock AJ, Sullivan CE. Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988; 137: 1502–4.
Petruson B, Theman K. Reduced nocturnal asthma by improved nasal breathing. Acta Otolaryngol 1996; 116: 490–2.
Gibson PG, Henry RL, Coughlan JL. Gastro-esophageal reflux treatment for asthma in adults and children. Cochrane Library 2005; 3.
Milledge JS, Morris J. A comparison of slow-release salbutamol with slow-release aminophyllin in nocturnal asthma. J Int Med Res 1979; 7: 106–10.
Postma DS, Koter GH, Mark TW, et al. The effects of oral slow-release terbutaline on circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 1985; 87: 653–7.
Wallaert B, Brun P, Ostinelli J, et al. A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group. Respir Med 1999; 93: 33–8.
Crompton GK, Ayres JG, Basran G, et al. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Am J Respir Crit Care Med 1999; 159: 824–8.
Brambilla C, Chastang C, Georges D, Bertin L. Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group. Allergy 1994; 49: 421–6.
Bensch G, Lapidus RJ, Levine BE, et al. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaled with albuterol metered-dose inhaler. Ann Allergy Asthma Immunol 2001; 86: 19–27.
Busse W, Levine B, Andriano K, Laveschia C, Yegen U. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Clin Ther 2004; 26: 1587–98.
Maesen FP, Smeets JJ, Gubbelmans HL, Zweers PG. Formoterol in the treatment of nocturnal asthma. Chest 1990; 98: 866–70.
Faurschou P, Engel AM, Haanaes OC. Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies. Allergy 1994; 49: 827–32.
Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405–11.
Norhaya MR, Yap TM, Zainudin BM. Addition of inhaled salmeterol to inhaled corticosteroids in patients with poorly controlled nocturnal asthma. Respirology 1999; 4: 77–81.
Ilowite J, Webb R, Friedman B, et al. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol 2004; 92: 641–8.
Lockey RF, DuBuske LM, Friedman B, et al. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. Chest 1999; 115: 666–73.
Kraft M, Wenzel SE, Bettinger CM, Martin RJ. The effect of salmeterol on nocturnal symptoms, airway function and inflammation in asthma. Chest 1997; 111: 1249–54.
Holimon TD, Chafin CC, Self TH. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting bet 2 agonists? Drugs 2001; 61: 391–418.
Elias-Jones AC, Higenbottam TW, Barnes ND, et al. Sustained release theophylline in nocturnal asthma. Arch Dis Child 1984; 59: 1159–61.
Bose B, Cater JI, Clark RA. A once daily theophylline preparations in prevention of nocturnal symptoms in childhood asthma. Eur J Pediatr 1987; 146: 524–7.
Martin RJ, Cicutto LC, Ballard RD. Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989; 139: 575–8.
Fairfax AJ, Clarke R, Chatterjee SS, et al. Controlled-release theophyllin in the treatment of nocturnal asthma. J Int Med Res 1990; 18: 273–81.
Rivington RN, Boulet LP, Cote J, et al. Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 1995; 151: 325–32.
Kraft M, Torvik JA, Trudeau JB, et al. Theophylline: potential anti-inflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996; 97: 1242–6.
Crescioli S, Carobbo AD, Maestrelli P, et al. Controlled-release theophylline inhibits early morning airway obstruction and hyperresponsiveness in asthmatic subjects. Ann Allergy Asthma Immunol 1996; 77: 106–10.
Grossman J. Multicenter comparison of once-daily uniphyl tablets administered in the morning or evening with baseline twice daily theophylline therapy in patients with nocturnal asthma. Am J Med 1988; 85: 11–3.
Cox ID, Hughes DTD, McDonnell KA. Ipratropium bromide in patients with nocturnal asthma. Postgrad Med J 1984; 60: 526–8.
Hughes DTD. The use of anticholinergic drugs in nocturnal asthma. Postgrad Med J 1987; 63 (Suppl): 47–51.
O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on metacholine induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 154: 876–80.
Beam WR, Weiner DE, Martin RJ. Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992; 146: 1524–30.
Frezza G, Terra-Filho J, Martinez JA, Vianna EO. Rapid effect of inhaled steroids on nocturnal worsening of asthma. Thorax 2003; 58: 632–3.
Pincus DJ, Szefler SJ, Ackerson LM, et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95: 1172–78.
Pincus DJ, Humeston TR, Martin RJ. Further studies on chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1997; 100: 771–4.
Horn CR, Clark TJH, Cochrane GM. Inhaled therapy reduces morning dips in asthma. Lancet 1984; I: 1143–5.
Leach CL. Improved delivery of inhaled steroids to the large and small airways. Respir Med 1998; 92 (Suppl A): 3–8.
Richards J, Hirst P, Pitcairn G, et al. Deposition and pharmacokinetics of flunisolide delivered from inhalers containing non-CFC and CFC propellants. J Aerosol Med 2001; 14: 197–208.
Corren J, Nelson H, Greos LS, et al. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerolsol in asthma patients. Ann Allergy Asthma Immunol 2001; 87: 405–11.
Molimard M, Martinat Y, Rogeaux Y, et al. Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. Respir Med 2005; 99: 770–8.
Bellia V, Bananno A, Cibella F, et al. Urinary leukotriene E4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996; 97: 735–41.
Wenzel SE, Tradeau JB, Kaminsky DA, et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152: 897–905.
Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med 1998; 158: 1213–20.
Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003; 58: 204–10.
Weersink EJ, Douma RR, Postma DS, Koeter GH. Fluticasone propionate, salmeterol xinofate, and their combination in the treatment of nocturnal asthma. Am J Respir Crit Care Med 1997; 155: 1241–6.
Ringdal N, Chuchalin A, Chovan L, et al. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 mg bd Discus) vs. formoterol (12 mg bd) and budesonide (800 mg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma. Respir Med 2002; 96: 851–61.
Canonica GW, Castellani P, Cazzola M, et al. Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing. Pulm Pharmacol Ther 2004; 17: 239–47.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer
About this chapter
Cite this chapter
Kowal, K., Buske, L.D. (2009). Mechanisms of Nocturnal Asthma. In: Pawankar, R., Holgate, S.T., Rosenwasser, L.J. (eds) Allergy Frontiers: Clinical Manifestations. Allergy Frontiers, vol 3. Springer, Tokyo. https://doi.org/10.1007/978-4-431-88317-3_14
Download citation
DOI: https://doi.org/10.1007/978-4-431-88317-3_14
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-88316-6
Online ISBN: 978-4-431-88317-3
eBook Packages: MedicineMedicine (R0)